ORL.news è un portale dedicato all’aggiornamento scientifico del medico e delle professioni sanitarie in otorinolaringoiatria. Notizie dalla ricerca, approfondimenti, video interviste e formazione medica continua: sono questi i pilastri del progetto.
ORL.news Podcast
Claim This Podcastby ORL.news
47 episodes
Updated Weekly
Accepts GuestsHas SponsorsLocation 🇮🇹
Podcast Overview
ORL.news è un portale dedicato all’aggiornamento scientifico del medico e delle professioni sanitarie in otorinolaringoiatria. Notizie dalla ricerca, approfondimenti, video interviste e formazione medica continua: sono questi i pilastri del progetto.
Language
🇮🇹
Publishing Since
2/22/2021
Reach the team behind ORL.news Podcast
Verified contact details for this show aren't on file yet — sign up to get notified when they land.
Recent Episodes
June 6, 2024
I dispositivi di connessione come strumento di inclusione sociale in pediatria
<p>Marco Marcato intervista Riccardo Bricca, Dottore in Tecniche Audioprotesiche, Amplifon.</p>
March 15, 2024
Mese dell'udito: focus sull'ORL pediatrica - con Eva Orzan e Marco Marcato
<p>Marco Marcato intervista Eva Orzan sui temi caldi di questa edizione del World Hearing Day, insieme ad una preview dei principali temi che verrano trattati al Congresso SIOP di aprile.</p>
November 7, 2022
Convegni internazionali 2022, i principali temi emersi - con Enrico Armato
<p style="font-weight:400;">In questo Episodio, Enrico Armato, Dirigente medico AULSS 3 Serenissima, Regione Veneto, racconta i principali temi emersi in 14 congressi nazionali ed internazionali, tenuti nel primo semestre 2022. Tra questi troviamo:</p> <ul style="font-weight:400;"><li>11ème Otoforum Marseille – Marzo,</li> <li>17th Annual Meeting of the Middle East Academy of Otolaryngology Head and Neck Surgery, Dubai – Marzo,</li> <li>24ème Assises d'ORL Nice – Aprile,</li> <li>XXXI Meeting of the Society Bárány, Madrid – Maggio,</li> <li>108° Congresso della Società Italiana di Otorinolaringoiatria, Roma – Maggio</li> </ul>
47 total episodes available
Deep-dive analytics for ORL.news Podcast
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is ORL.news Podcast?
- How often does this podcast release new episodes?
This podcast updates weekly.
- Where can I listen to this podcast?
This podcast is available on 8 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.